Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut für Pharmakologie und Präventive Medizin (IPPM) is a German clinical research organization and private institute specializing in pharmacology and preventive health. Based in Cloppenburg, the institute provides comprehensive services for the planning and execution of clinical trials, primarily focusing on Phase II-IV studies. Its scientific expertise covers cardiovascular medicine, metabolic disorders, and nutritional science, supporting the pharmaceutical industry in drug development and validation. Led by Prof. Dr. Bernd-Michael Löffler, IPPM also offers specialized diagnostics and consulting in sports medicine and preventive care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut für Pharmakologie und Präventive Medizin.